IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. JE Vince, WW Wong, N Khan, R Feltham, D Chau, AU Ahmed, ... Cell 131 (4), 682, 2007 | 1262 | 2007 |
The molecular targets and therapeutic uses of curcumin in health and disease BB Aggarwal, YJ Surh, S Shishodia Springer Science & Business Media, 2007 | 535 | 2007 |
A fourth IκB protein within the NF-κB signaling module S Basak, H Kim, JD Kearns, V Tergaonkar, E O'Dea, SL Werner, ... Cell 128 (2), 369-381, 2007 | 505 | 2007 |
A circRNA from SEPALLATA3 regulates splicing of its cognate mRNA through R-loop formation VM Conn, V Hugouvieux, A Nayak, SA Conos, G Capovilla, G Cildir, ... Nature plants 3 (5), 1-5, 2017 | 493 | 2017 |
p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy V Tergaonkar, M Pando, O Vafa, G Wahl, I Verma Cancer cell 1 (5), 493-503, 2002 | 416 | 2002 |
Multifaceted link between cancer and inflammation G Sethi, MK Shanmugam, L Ramachandran, AP Kumar, V Tergaonkar Bioscience reports 32 (1), 1-15, 2012 | 403 | 2012 |
NF-[kappa] B controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration C Mauro, SC Leow, E Anso, S Rocha, AK Thotakura, L Tornatore, ... Nature cell biology, 2011 | 396 | 2011 |
Telomerase directly regulates NF-κB-dependent transcription A Ghosh, G Saginc, SC Leow, E Khattar, EM Shin, TD Yan, M Wong, ... Nature Cell Biology, 2012 | 387 | 2012 |
Chronic adipose tissue inflammation: all immune cells on the stage G Cildir, SC Akıncılar, V Tergaonkar Trends in molecular medicine 19 (8), 487-500, 2013 | 378 | 2013 |
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy HM Shen, V Tergaonkar Apoptosis 14 (4), 348-363, 2009 | 356 | 2009 |
NFκB pathway: a good signaling paradigm and therapeutic target V Tergaonkar The international journal of biochemistry & cell biology 38 (10), 1647-1653, 2006 | 350 | 2006 |
Noncanonical NF-κB signaling in health and disease G Cildir, KC Low, V Tergaonkar Trends in molecular medicine 22 (5), 414-429, 2016 | 321 | 2016 |
Telomerase: central regulator of all of the hallmarks of cancer KC Low, V Tergaonkar Trends in biochemical sciences 38 (9), 426-434, 2013 | 289 | 2013 |
Roles of NF-κB in health and disease: mechanisms and therapeutic potential ET Wong, V Tergaonkar Clinical science 116 (6), 451-465, 2009 | 267 | 2009 |
Reactivation of telomerase in cancer SC Akincilar, B Unal, V Tergaonkar Cellular and Molecular Life Sciences 73, 1659-1670, 2016 | 255 | 2016 |
Telomere-independent Rap1 is an IKK adaptor and regulates NF-[kappa] B-dependent gene expression H Teo, S Ghosh, H Luesch, A Ghosh, ET Wong, N Malik, A Orth, ... Nature cell biology 12 (8), 758-767, 2010 | 242 | 2010 |
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds MK Shanmugam, JH Lee, EZP Chai, MM Kanchi, S Kar, F Arfuso, ... Seminars in cancer biology 40, 35-47, 2016 | 225 | 2016 |
ATM and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress ZH Wu, ET Wong, Y Shi, J Niu, Z Chen, S Miyamoto, V Tergaonkar Molecular cell 40 (1), 75, 2010 | 221 | 2010 |
Potential pharmacological control of the NF-κB pathway G Sethi, V Tergaonkar Trends in pharmacological sciences 30 (6), 313-321, 2009 | 211 | 2009 |
WIP1 phosphatase is a negative regulator of NF-κB signalling J Chew, S Biswas, S Shreeram, M Humaidi, ET Wong, MK Dhillion, H Teo, ... Nature cell biology 11 (5), 659-666, 2009 | 207 | 2009 |